24 Active Ingredients in BrainAlert

Ingredients Supplement Facts

Limited Time Offer of 30% Off
With Free Shipping!*
Buy Now Risk Free


Quantity:
Secure Payments with PayPal

  1. Acetyl-l-carnitine
  2. Bacopa Monniera
  3. Bioperine®
  4. Citicholine
  5. CoQ10
  6. DMAE
  7. Folic Acid
  8. Ginkgo Biloba
  9. Gotu Kola
  10. Huperzine A
  11. L-Carnosine
  12. Methylcobalamin
  13. N-Acetyl Tyrosine
  14. Panax Ginseng
  15. Phosphatidylserine
  16. R-Alpha Lipoic Acid
  17. Rhodiola Rosea
  18. Trimethylglycine
  19. Vinpocetine
  20. Vitamin B1 Thiamine
  21. Vitamin B2 Riboflavin
  22. Vitamin B3 Niacinamide
  23. Vitamin B5 Pantothenic Acid
  24. Vitamin B6 Pyridoxine

Acetyl-l-carnitine

Top of Page

Bacopa Monniera

Top of Page

Bioperine®

Top of Page

Citicholine

Top of Page

CoQ10

Top of Page

DMAE

Top of Page

Folic Acid

Top of Page

Ginkgo Biloba

Top of Page

Gotu Kola

Top of Page

Huperzine A

Top of Page

L-Carnosine

Top of Page

Methylcobalamin

Top of Page

N-Acetyl Tyrosine

Top of Page

Panax Ginseng

Top of Page

Phosphatidylserine

Top of Page

R-Alpha Lipoic Acid

Top of Page

Rhodiola Rosea

Top of Page

Trimethylglycine

Top of Page

Vinpocetine

Top of Page

Vitamin B1 Thiamine

Top of Page

Vitamin B2 Riboflavin

Top of Page

Vitamin B3 Niacinamide

Top of Page

Vitamin B5 Pantothenic Acid

Top of Page

Vitamin B6 Pyridoxine

Top of Page  
Order Now


References
1. Fernandez E, Pallini R, Lauretti L, La Marca F, Sccgna A, Rossi GF, Center for Research in Regeneration of the Nervous System, Catholic University Medical School, Rome, Italy. Motonuclear changes after cranial nerve injury and regeneration. Arch Ital Biol (Italy) 1997 Sep;135(4):343-51.
2. Amenta F, Ferrante F, Lucreziotti R, Ricci A, Ramacci MT, Dipartimento di Scienze Neurologiche, Universita La Sapienza, Rome, Italy. Reduced lipofuscin accumulation in senescent rat brain by long-term acetyl-L-carnitine treatment. Arch Gerontol Geriatr 1989 Sep-Oct;9(2):147-53.
3. Di Donato S, Frerman FE, Rimoldi M, Rinaldo P, Taroni F, Wiesmann UN. Systemic carnitine deficiency due to lack of electron transfer flavoprotein: ubiquinone oxidoreductase. Neurology 1986 Jul;36(7):957-63.
4. Schonheit K, Gille L, Nohl H, Institute of Pharmacology and Toxicology, Veterinary University of Vienna, Austria. Effect of alpha-lipoic acid and dihydrolipoic acid on ischemia/reperfusion injury of the heart and heart mitochondria. Biochim Biophys Acta 1995 Jun 9;1271(2-3):335-42.
5. Salvioli G, Neri M. L-acetylcarnitine treatment of mental decline in the elderly. Drugs Exp Clin Res 1994;20(4):169-76.
6. Salvioli G, Neri M. L-acetylcarnitine treatment of mental decline in the elderly. Drugs Exp Clin Res 1994;20(4):169-76.
7. Kuboyama T, Tohda C, Zhao J, Nakamura N, Hattori M, Komatsu K. Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha. Neuroreport. 2002 Oct 7;13(14):1715-20.
8. Tohda C, Kuboyama T, Komatsu K. Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK-N-SH cells. Neuroreport. 2000 Jun 26;11(9):1981-5.
9. Bhattacharya A, Ghosal S, Bhattacharya SK. Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. J Ethnopharmacol. 2001 Jan;74(1):1-6.
10. Schliebs R, Liebmann A, Bhattacharya SK, Kumar A, Ghosal S, Bigl V. Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int. 1997 Feb;30(2):181-90.
11. Sekar P. Vedic clues to memory enhancer. The Hindu, March 21, 1996.
12. Ganguly DK, Malhotra CL. Some behavioural effects of an active fraction from Herpestis monniera Linn. (Brahmi). Indian J Physiol Pharmacol 1969 Jul;13(3):163-7.
13. Central Drug Research Institute, Lucknow, India. NLAC-Newsletter, Spring 1996.
14. Sharma R, Chaturvedi C, Tewari PV. Efficacy of Bacopa monierra in revitalizing intellectual functions in children. J Rees Edu Ind Med 1987:1-12.
15. Abhang R. Study to evaluate the effect of a micro (Suksma) medicine derived from Brahmi (Herpestis monniera) on students of average intelligence.
J Res Ayur Siddha 1993 14(1-2):10-21
16. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berl) 2001 Aug;156(4):481-4
17. Velpandian, T., Jasuja, R., Bhardwaj, R.K., Jaiswal, J., & Gupta, S.K. (2001). Piperine in food: interference in the pharmacokinetics of phenytoin. European Journal of Drug Metabolism and Pharmacokinetics, 26, 241-247
18. Badmaev, V. V., Majeed, M., & Prakash, L. (2000). Piperine derived from black pepper increases the plasma levels of coenzyme q10 following oral supplementation. Journal of Nutritional Biochemistry, 11, 109-113
19. Stuerenburg HJ, Kunze K. Concentrations of free carnosine (a putative membrane-protective antioxidant) in human muscle biopsies and rat muscles. Arch Gerontol Geriatr. 1999. 29: 107-113.
20. McFarland GA, Holliday R. Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp Cell Res 1994; 212(2):167-75.
21. Yuneva MO, Bulygina ER, Gallant SC, et al. Effect of carnosine on age-induced changes in senescence-accelerated mice. J Anti-Aging Med. 1999; 2(4):337-42.
22. Boldyrev A, Song R, Lawrence D, et al. Carnosine protects against excitotoxic cell death independently of effects on reactive oxygen species. Neuroscience. 1999; 94(2):571-7.
23. Pyapili GK, Turner DA, Williams, CL. Prenatal dietary choline supplementation decreases the threshold for induction of long-term potentiation in young adult rats. J Neurophysiol. 1998; 79:1790-1796.
24. Buchman, A.L., et al. 2001. Verbal and visual memory improve after choline supplementation in long-term total parenteral nutrition: A pilot study. Journal of Parenteral and Enteral Nutrition 25(January-February):30.
25. Mortensen SA, Vadhanavikit S, Baandrup U, Folkers K. Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure. Drug Exptl Clin Res 1985;11:581-93.
26. Soja AM, Mortensen SA. Treatment of chornic cardiac insufficiency with coenzyme Q10, results of meta-analysis in controlled clinical trials. Ugeskr Laeger 1997;159:7302
27. Shults CW, Oakes D, Kieburtz K, Beal F, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, Kurlan R, Molho E, Harrison M, Lew M, and the Parkinson Study Group. "Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline." Archives of Neurology , October 2002, Vol. 59, No. 10, pp. 1541-1550.
28. Lewis JA, Young R. Deanol and methylphenidate in minimal brain dysfunction. Clin Pharmacol Ther. 1975;17:534-540.
29. Re O. 2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action. Curr Ther Res Clin Exp. 1974 Nov;16(11):1238-42.
30. Sergio W. Use of DMAE (2-dimethylaminoethanol) in the induction of lucid dreams. Med Hypotheses. 1988;26:255-257.
31. Pfeiffer CC, et al. Stimulant effect of 2-dimethyl-l-aminoethanol: possible precursor of brain acetylcholine. Science. 1957;126:610-611.
32. Pfeiffer CC. Parasympathetic neurohumors. Possible precursors and effect on behavior. International Review of Neurobiology. 1959:195-244.
33. New research reveals lifestyle habits linked to risk of getting Alzheimer's. 28 June. 2005. Alzheimer's Association. 8 Oct. 2005 < http://www.alz.org/preventionconference/pc2005/062805folate.asp >. 
34. http://www.nutraingredients.com/news/ng.asp?id=60780
35. Blumenthal M. Herb sales down 15 percent in mainstream market. HerbalGram 2001;51:68. 
36. Mix JA, Crews WD. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings. Human Psychopharmacol Clin Exp 2002;17:267-77.
37. Birks J, Grimley Evans J, Van Dongen M. Ginkgo Biloba for Cognitive Impairment and Dementia (Cochrane Review). In: The Cochrane Library, Issue 4, 2002. Oxford: Update Software.
38. Birks J, Grimley Evans J, Van Dongen M. Ginkgo Biloba for Cognitive Impairment and Dementia (Cochrane Review). In: The Cochrane Library, Issue 4, 2002. Oxford: Update Software
39. Mix JA, Crews WD. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings. Human Psychopharmacol Clin Exp 2002;17:267-77.
40. A Double-Blind, Placebo-Controlled Study on the Effects of Gotu Kola (Centella asiatica) on Acoustic Startle Response in Healthy Subjects. 
Journal of Clinical Psychopharmacology. 20(6):680-684, December 2000.
Bradwejn, Jacques MD, FRCPC; Zhou, Yueping MD, PhD; Koszycki, Diana PhD ; Shlik, Jakov MD, PhD
41. Bradwejn J, Zhou Y, Koszycki D, et al. A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects. J Clin Psychopharmacol. 2000;20:680-684.
42. Nalini K, Aroor AR, Karanth KS, et al. Effect of Centella asiatica fresh leaf aqueous extract on learning and memory and biogenic amine turnover in albino rats. Fitoterapia. 1992;63:232-237.
43. Ashani Y, Peggins JO 3d, Doctor BP. Mechanism of inhibition of cholinesterases by huperzine A. Biochem Biophys Res Commun 1992;184:719-26.
44. Sun QQ, et al. Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students. Chung Kuo Yao Li Hsueh Pao 1999 Jul;20(7):601-3.
45. Cheng DH, Ren H, Tang XC. Huperzine A, a novel promising acetylcholinesterase inhibitor. Neuroreport. 1996;8:97-101.
46. Cheng DH, Tang XC. Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities. Pharmacol Biochem Behav. 1998;60:377-386.
47. Xiong ZQ, Tang XC. Effect of huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats. Pharmacol Biochem Behav. 1995;51:415-419.
48. Zhi QX, Yi FH, XI CT. Huperzine A ameliorates the spatial working memory impairments induced by AF64A. Neuroreport. 1995;6:2221-2224.
49. Zhu XD, Giacobini E. Second generation cholinesterase inhibitors: effect of (L)-huperzine-A on cortical biogenic amines. J Neurosci Res. 1995;41:828-835.
50. Zhang GB, Wang MY, Zheng JQ, et al. Facilitation of cholinergic transmission by huperzine A in toad paravertebral ganglia in vitro [in Chinese; English abstract]. Zhongguo Yao Li Xue Bao. 1994;15:158-161.
51. Laganiere S, Corey J, Tang XC, et al. Acute and chronic studies with the anticholinesterase Huperzine A: effect on central nervous system cholinergic parameters. Neuropharmacology. 1991;30:763-768.
52. Tang XC, De Sarno P, Sugaya K, et al. Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat. J Neurosci Res. 1989;24:276-285.
53. Tang XC, Han YF, Chen XP, et al. Effects of huperzine A on learning and the retrieval process of discrimination performance in rats [in Chinese]. Zhongguo Yao Li Xue Bao. 1986;7:507-511. 
54. Guan LC, Chen SS, Lu WH, et al. Effects of huperzine A on electroencephalography power spectrum in rabbits [in Chinese; English abstract]. Zhongguo Yao Li Xue Bao. 1989;10:496-500. 
55. Lu WH, Shou J, Tang XC. Improving effect of huperzine A on discrimination performance in aged rats and adult rats with experimental cognitive impairment [in Chinese]. Zhongguo Yao Li Xue Bao. 1988;9:11-15.
56. Wang YE, Feng J, Lu WH. Pharmacokinetics of huperzine A in rats and mice [in Chinese]. Zhongguo Yao Li Xue Bao. 1988;9:193-196.
57. Wang YE, Yue DX, Tang XC. Anti-cholinesterase activity of huperzine A [in Chinese]. Zhongguo Yao Li Xue Bao. 1986;7:110-113.
58. Zhu XD, Tang XC. Improvement of impaired memory in mice by huperzine A and huperzine B [in Chinese]. Zhongguo Yao Li Xue Bao. 1988;9:492-497.
59. Zhu XD, Tang XC. Facilitatory effects of huperzine A and B on learning and memory of spatial discrimination in mice [in Chinese]. Yao Xue Xue Bao. 1987;22:812-817.
60. Yan XF, Lu WH, Lou WJ, et al. Effects of huperzine A and B on skeletal muscle and the electroencephalogram [in Chinese]. Zhongguo Yao Li Xue Bao. 1987;8:117-123.
61. Ved HS, Koenig ML, Dave JR, et al. Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate. Neuroreport. 1997;8:963-968.
62. Zhou J, Zhang HY, Tang XC. Huperzine A attenuates cognitive deficits and hippocampal neuronal damage after transient global ischemia in gerbils. Neurosci Lett. 2001;313:137-140.
63. Zhou J, Fu Y, Tang XC. Huperzine A protects rat pheochromocytoma cells against oxygen-glucose deprivation. Neuroreport. 2001;12:2073-2077.
64. Wang LM, Han YF, Tang XC. Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats. Eur J Pharmacol. 2000;398:65-72. 
65. (1993 Sep.7; 7; 241 (1): 1-6), it was shown that ethylcobalamin protected against glutamate-, aspartate- and nitroprusside- induced neurotoxicity in rat cortical neurons
66. Clinical Therapeutics (1992 May; 14(3): 426-437)
67. Neuropharmacology (15[5]: 456-464, 1996)
68. Journal of Neurological Science (1994 Apr. 122[2]:140-143)
69. Farmakol Toksikol (1983 Nov; 46[6]: 9-12) Nov 1983)
70. Neurological Disease: A Potential Breakthrough. Life Extension Magazine. Aug. 1998.
71. Gelenberg AJ, Gibson CJ, Wojcik JD. Neurotransmitter precursors for the treatment of depression. Psychopharmacol Bull 1982;18:7-18.
72. Banderet LE, Lieberman HR. Treatment with tyrosine a neurotransmitter precursor, reduces environmental stress in humans. Brain Res Bull 1989;22:759-62.
73. Lieberman, HR, Corkin S, Spring BJ, Wurtman RJ, and Growden JH. The effects of dietary neurotransmitter precursors on human behavior. Am J Clin Nutr 42: 366-370, 1985.
74. Mahady GB, Gyllenhall C, Fong HH, Farnsworth NR. Ginsengs: a review of safety and efficacy. Nutr Clin Care 2000;3:90-101.
75. Vogler BK, Pittler MH, Ernst E. The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol 1999;55:567-75.
76. Sorensen H, Sonne J. A double-masked study of the effects of ginseng on cognitive functions. Curr Ther Res Clin Exp 1996;57:959-68.
77. D'Angelo L, Grimaldi R, Caravaggi M, Marcoli M, Perucca E, Lecchini S, et al. A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers. J Ethnopharmacol 1986;16:15-22.
78. Ellis JM, Reddy P. Effects of Panax ginseng on quality of life. Ann Pharmacother 2002;36:375-9.
79. Kennedy DO, Scholey AB, Wesnes KA. Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults. Physiol Behav 2002;75:739-51.
80. Scaglione F, Cattaneo G, Alessandria M, Cogo R. Efficacy and safety of the standardized Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected]. Drugs Exp Clin Res 1996;22:65-72.
81. "Ginseng may reduce number, severity of colds". (Nov. 6, 2005). New Sunday Times, p. F19.
82. Yun TK, Choi SY. Non-organ specific cancer prevention of ginseng: a prospective study in Korea. Int J Epidemiol 1998;27:359-64.
83. Double-blind study of a multivitamin complex supplemented with ginseng extract. Caso Marasco A, Vargas Ruiz R, Salas Villagomez A, Begona Infante C. Universidad Nacional Autonoma (UNAM), Mexico. Drugs Exp Clin Res. 1996;22(6):323-9.
84. Kagan V, Khan S, Swanson C, et al. Antioxidant action of thioctic acid and dihydrolipoic acid. Free Radic Biol Med 1990;9S:15.
85. Kagan V, Serbinova E, Packer L. Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling. Biochem Biophys Res Commun 1990;169:851-7.
86. Lykkesfeldt J, Hagen TM, Vinarsky V, Ames BN. Age-associated decline in ascorbic acid concentration, recycling, and biosynthesis in rat hepatocytes-reversal with (R)-alpha-lipoic acid supplementation. FASEB J 1998;12:1183-9.
87. Scholich H, Murphy ME, Sies H. Antioxidant activity of dihydrolipoate against microsomal lipid peroxidation and its dependence on alpha-tocopherol. Biochem Biophys Acta 1989;1001:256-61.
88. Hagen, T.M., Liu, J., Lykkesfeldt, J., Wehr, C.M., Ingersoll, R.T., Vinarsky, V., Bartholomew, J.C., & Ames, B.N. (2002). Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proceedings of the National Academy of Sciences, 99, 1870-1875
89. Liu, J., Head, E., Gharib, A.M., Yuan, W., Ingersoll, R.T., Hagen, T.M., Cotman, C.W., & Ames, B.N. (2002). Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid Proceedings of the National Academy of Sciences, 99, 2356-2361
90. Liu, J., Killilea, D.W., & Ames, B.N. (2002). Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid. Proceedings of the National Academy of Sciences, 99, 1876-1881
91. Brown RP, Gerbarg PL, Ramazanov Z. Rhodiola rosea: a phytomedicinal overview. Herbalgram 2002;56:40-52.
92. Int J Sport Nutr Exerc Metab. 2004 Jun;14(3):298-307.
93. Phytomedicine. 2003 Mar;10(2-3):95-105.
94. Saratikov AS, Krasnov EA. Rhodiola rosea is a valuable medicinal plant (Golden Root). Tomsk, Russia: Tomsk State University Press; 1987.
95. Darbinyan V, Kteyan A, Panossian A, Gabrielian E, Wikman G, Wagner H. Rhodiola rosea in stress induced fatigue: a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine 2000;7(5):365-71.
96. Saratikov AS. Golden Root (Rhodiola rosea). Tomsk, Russia: Tomsk State University Press; 1974.
97. Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine 2000;7(2):85-9.
98. Spasov AA, Mandrikov VB, Mironova IA. The effect of the preparation rhodiosin on the psychophysiological and physical adaptation of students to an academic load. Eksp Klin Farmakol 2000;63(1):76-8.
99. Furmanowa M, Oledzka H, Michalska M, Sokolnicka I, Radomska D. Chapter XXIII Rhodiola rosea L. (Roseroot): In vitro regeneration and the biological activity of roots. 
100. Vol. 33. In: Bajaj YPS, editor. Biotechnology in Agriculture and Forestry. Vol. 33. Medicinal and aromatic plants. VIII. Berlin and Heidelberg, Germany: Springer-Verlag; 1995. p. 412-26.
101. Zatova MI, Krilov GV, Saratikov AS. Golden root: new stimulative and adaptogenic drug. Proceedings of Siberian Academy of Sciences. Biological and Medical Sciences. 1965;2:111-9.
102. Saratikov AS. Screening for natural central nervous system stimulants. In: Saratikov AS, editor. Stimulants of the Central Nervous System. Vol. 1. Tomsk, Russia: Tomsk State University Press; 1966 p. 3-23.
103. Darbinyan V, Kteyan A, Panossian A, Gabrielian E, Wikman G, Wagner H. Rhodiola rosea in stress induced fatigue: a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine 2000;7(5):365-71.
104. Krasik ED, Petrova KP, Rogulina GA, Shemetova LYa, Shuvayeva. New data on the therapy of asthenic conditions (clinical prospects for the use of Rhodiola extract). Proceedings of All-Russia Conference: Urgent Problems in Psychopharmacology 1970 May 26-29. Sverdlovsk, Russia: Sverdlovsk Press; 1970. p. 215-7.
105. Spasov AA, Mandrikov VB, Mironova IA. The effect of the preparation rhodiosin on the psychophysiological and physical adaptation of students to an academic load. Eksp Klin Farmakol 2000;63(1):76-8.
106. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999;19:217-46 [review].
107. Barak AJ, Tuma DJ. Betaine, metabolic by-product or vital methylating agent? Life Sci 1983;32:771-4 [review].
108. Barak AJ, Beckenhauer HC, Tuma DJ. Betaine, ethanol and the liver: a review. Alcohol. 1996;13:395-398.
109. Barak AJ, Beckenhauer HC, Junnila M, et al. Dietary betaine promotes generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration. Alcohol Clin Exp Res. 1993;17:552-555.
110. Murakami T, Nagamura Y, Hirano K. The recovering effect of betaine on carbon tetrachloride-induced liver injury. J Nutr Sci Vitaminol. 1998;44:249-255.
111. Kanbak G, Inal M, Baycu C. Ethanol-induced hepatotoxicity and protective effect of betaine. Cell Biochem Funct. 2001;19:281-285.
112. Benton D, Griffiths R, Haller J. Thiamine supplementation mood and cognitive functioning. Psychopharmacology (Berl) 1997;129(1):66-71.
113. Benton D, Fordy J, Haller J. The impact of long-term vitamin supplementation on cognitive functioning. Psychopharmacology (Berl) 1995;117(3):298-305.
114. McDaniel MA, Maier SF, Einstein GO. "Brain-specific" nutrients: a memory cure? Nutrition 2003, Nov-Dec;19(11-12):957-75.
115. McDaniel MA, Maier SF, Einstein GO. "Brain-specific" nutrients: a memory cure? Nutrition 2003, Nov-Dec;19(11-12):957-75.
116. Coleston, D.M. and Hindmarh, I. Possible memory-enhancing properties or vinpocetine. Drug.Dev. Res. , 14:191-193 (1988)
117. Miyazaki , M. Correlation between cerebral circulation and intellectual impairment in patients with aging Brain, and the effect of vinpocetine on cerebral circulation. Drug. Dev. Res, 14:199-204 (1988).
118. Hayakawa, M. Effect of vinpocetine on red blood cells deformability in stroke patients. Arzneim-Forsch. 42:425-427 (1997).
119. Reference: European Journal of Neurology; 2004, Vol. 11, 475-7.
120. Elliott RB, Pilcher CC, Fergusson DM, et al. A population based strategy to prevent insulin-dependent diabetes using nicotinamide. J Pediatr Endocrinol Metab. 1996;9:501-509.
121. Pozzilli P, Visalli N, Signore A, et al. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study). Diabetologia. 1995;38:848-852.
122. Polo V, Saibene A, Pontiroli AE. Nicotinamide improves insulin secretion and metabolic control in lean type 2 diabetic patients with secondary failure to sulphonylureas. Acta Diabetol. 1998;35:61-64.
123. Jonas WB, Rapoza CP, Blair WF. The effect of niacinamide on osteoarthritis: a pilot study. Inflamm Res. 1996;45:330-334.
124. Hoffer A. The vitamin paradigm wars. Townsend Letters for Doctors and Patients 1996;June:56-60.
125. Hoffer A. Safety, side effects and relative lack of toxicity of nicotinic acid and nicotinamide. Schizophrenia 1969;1:78-87.
126. Goodman AG, et al. Goodman and Gilman's The Pharmacological Basis of Therapeutics. Eighth Edition, New York, Pergamon Press, 1990.
127. Murray M, Pizzorno J. Encyclopedia of Natural Medicine. Second Edition. Rocklin, CA, Prima Health, 1998.
128. Anand JC. Osteoarthritis and pantothenic acid. Journal of the College of General Practice 5:136-7, 1963.
129. "Vitamin B6." BBC News. 8 June 2004. 7 Oct. 2005 <http://searchenginewatch.com/searchday/article.php/3398511>.
130. Leklem JE. Vitamin B6. In: Shils ME, Olson JA, Shike M, Ross AC, ed. Modern Nutrition in Health and Disease. 9th ed. Baltimore: Williams and Wilkins, 1999: 413-421.
131. U.S. Department of Agriculture, Agricultural Research Service,1999. USDA Nutrient Database for Standard Reference, Release 13. Nutrient Data Lab Home Page, http://www.nal.usda.gov/fnic/foodcomp
132. Malouf M, Grimley EJ, Areosa SA. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev. 2003;(4):CD004514.
133. Deijen JB, van der Beek EJ, Orlebeke JF, van den BH. Vitamin B-6 supplementation in elderly men: effects on mood, memory, performance and mental effort. Psychopharmacology (Berl). 1992;109(4):489-96.
Home | How It Works | Ingredients | Testimonials | FAQs | Contact | About Us | Order Now
100% Money Back Guarantee | Privacy Statement
© Copyright 2014 BrainAlert LLC